ArticleFrontiers in pharmacology2024

A single intraarticular injection of a tranexamic acid-modified hyaluronic acid (HA/TXA) alleviates pain and reduces OA development in a murine model of monosodium iodoacetate-induced osteoarthritis.

Sybille Brochard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.